U.S. Stock News

Jacobs Solutions (J) has drawn fresh attention after reporting Q2 2026 results that paired organic net revenue growth and margin expansion with raised full year guidance and strong demand in AI and data center infrastructure. See our latest analysis for Jacobs Solutions. Even with the upbeat Q2 update and fresh contract wins in Nashville and Sydney, the stock has lost ground recently, with a 90 day share price return of 17.51% and year to date share price return of 9.30%, while the 3 year...

In early May 2026, Ocugen reported first-quarter revenue of US$1.53 million alongside a net loss of US$19.18 million, while also closing a US$115 million private offering of 6.75% Convertible Senior Notes due 2034 and using about US$32.7 million to retire its Avenue loan. These updates both highlight Ocugen’s ongoing cash burn and materially improve its liquidity profile, with management indicating the new financing extends the company’s cash runway and supports continued advancement of its...

Recent trading in Ollie's Bargain Outlet Holdings (OLLI) has drawn attention, with the stock showing negative returns over the past week, month and past 3 months, even as revenue and net income figures remain in the billions of US dollars. See our latest analysis for Ollie's Bargain Outlet Holdings. At a share price of $81.77, Ollie's Bargain Outlet Holdings has experienced a 27.32% decline in its 3 month share price and a 24.94% decline in its 1 year total shareholder return. However, the 3...

In recent months, YETI Holdings has reported stronger-than-expected fourth-quarter results, with revenue and earnings supported by a rebound in drinkware sales and a 25% uplift in international revenue. At the same time, a major institutional investor fully exited its position while analysts debate how tariffs and higher spending might affect YETI’s otherwise resilient, internationally expanding brand. Now we’ll explore how this renewed strength in drinkware and international expansion...

Suburban Propane Partners (SPH) opened Q1 2026 with revenue of US$370.4 million and basic EPS of US$0.69, while trailing 12 month revenue sat at US$1.4 billion and basic EPS at US$2.03. Over the past year, revenue on a trailing 12 month basis moved from US$1.3 billion in Q4 2024 to US$1.4 billion in Q1 2026, with basic EPS over that same span shifting from US$1.15 to US$2.03. For investors, the latest quarter sets the stage for a closer look at how much of this earnings profile is being...

Slide Insurance Holdings (NasdaqGS:SLDE) has entered the California market with a new excess and surplus lines residential property insurance program. The company has written its first California policy, marking the start of its operations in one of the largest U.S. property insurance markets. For investors watching property insurers, California represents a complex and heavily scrutinized market, especially for residential coverage. By using an excess and surplus lines structure, Slide...

In late April 2026, AerCap Holdings reported higher first‑quarter revenue of US$2,241.73 million and net income of US$818.13 million year over year, raised its full‑year 2026 earnings guidance, announced a new US$1.00 billion share repurchase program running through December 31, 2026, and affirmed a US$0.40 quarterly dividend. Together with recent buyback completions, these moves signal AerCap’s focus on returning cash to shareholders while capitalizing on strong demand for aviation assets...

Recent performance snapshot Monte Rosa Therapeutics (GLUE) has drawn investor attention after recent share price moves, with the stock last closing at $19.81 and delivering a return of 15.7% over the past month. See our latest analysis for Monte Rosa Therapeutics. While the recent 15.7% one-month share price return has been strong, the 29.4% year-to-date share price return and very large one-year total shareholder return suggest that momentum has been building over a longer period. If you are...

Upwork (UPWK) has just wrapped FY 2025 with fourth quarter revenue of US$198.4 million and basic EPS of US$0.12, alongside net income of US$15.6 million. This rounds out a year where trailing twelve month revenue came in at US$787.8 million and EPS at US$0.87. Over recent quarters the company has seen revenue move from US$191.5 million in Q4 2024 to between US$192.7 million and US$201.7 million across FY 2025, while quarterly EPS has ranged from US$0.12 to US$0.28. This sets up a story that...

Invesco Ltd. has reported past first-quarter 2026 results showing revenue of US$1,744.5 million and net income of US$268.6 million, alongside higher earnings per share, increased common and preferred dividends, and ongoing share repurchases. The combination of stronger quarterly performance, continued net inflows, and the launch of a new US$1 billion buyback program highlights management’s focus on returning capital while growing assets under management. Next, we’ll examine how Invesco’s...

The opening of the Gainesville Inland Port, with direct rail service from Norfolk Southern (NSC) five days a week, is drawing new attention to how this freight corridor could affect the stock. See our latest analysis for Norfolk Southern. The recent opening of the Gainesville Inland Port and Norfolk Southern's upcoming appearance at the Bank of America Industrials, Transportation & Airlines conference come against a backdrop of a 30 day share price return of 8.63% and a 1 year total...

In recent weeks, UnitedHealth Group reported Q1 2026 results showing revenues of US$111.70 billion and net earnings of US$6.48 billion, while also outlining portfolio divestitures, pending acquisitions, share repurchases, and plans to remove prior authorization requirements for a significant share of services by 2026. These moves, alongside improved margins, updated 2026 guidance and efforts to simplify care approvals, highlight how UnitedHealth is reshaping its operations to address cost...

European Commission approves Sotyktu (deucravacitinib) for adults with active psoriatic arthritis. First TYK2 inhibitor cleared for this indication in the European Union. Label expansion adds a once daily oral option for patients with limited treatment choices. Bristol-Myers Squibb (NYSE:BMY), trading at $56.25, now has an expanded EU label for Sotyktu that reflects its efforts in immunology. The stock is up 26.0% over the past year and 5.2% year to date, while longer multiyear returns have...

Cloudflare FY 2025 earnings snapshot Cloudflare (NET) has wrapped up FY 2025 with fourth quarter revenue of US$614.5 million and basic EPS of a US$0.03 loss, alongside a trailing twelve month revenue base of about US$2.2 billion and a net loss of US$102.3 million. Over recent periods the company has seen revenue move from US$430.1 million in Q3 2024 to US$614.5 million in Q4 2025, while quarterly basic EPS has ranged between a loss of US$0.15 and a loss of US$0.00, underscoring an ongoing...

In early May 2026, Allegro MicroSystems reported past fourth-quarter and full-year results showing higher sales but continued net losses, while issuing first-quarter 2027 guidance for US$245 million to US$255 million in net sales, implying 23% year-over-year growth at the midpoint. The combination of strong automotive and rapidly expanding data center sales, alongside efforts to offset input cost pressures with copper wiring and surcharges, signals an evolving business mix focused on...

In the first quarter of 2026, Caesars Entertainment reported higher sales of US$2,153 million and revenue of US$2,870 million, while reducing its net loss to US$98 million compared with the prior year. Alongside these improved results, Caesars has been expanding its entertainment offerings with new venues such as OMNIA Dayclub & Skybar in Las Vegas and the upcoming Caesars Beach Club in Atlantic City, aiming to draw more visitors to its properties. Next, we will examine how Caesars’ narrowed...

Protagonist Therapeutics reported first-quarter 2026 results that swung to a net income of US$3.78 million, helped by a US$50 million milestone payment linked to FDA approval of ICOTYDE and a US$200 million payment from restructuring its rusfertide collaboration. These developments not only produced an unexpected profit but also shifted Protagonist’s business model toward milestone- and royalty-based revenues backed by liquidity of about US$620.3 million. Next, we’ll examine how this move...

Vertex Pharmaceuticals (NasdaqGS:VRTX) has secured a reimbursement agreement in Germany for its CASGEVY gene therapy for sickle cell disease and beta thalassemia. This is Germany's first long term access deal for a gene edited therapy of this kind, supporting broader patient access within the country. The agreement expands CASGEVY access in Europe and adds to Vertex's efforts to build revenue beyond its cystic fibrosis portfolio. For investors tracking NasdaqGS:VRTX, the new German...

In the first quarter of 2026, Centene Corporation reported revenue of US$49.94 billion and net income of US$1.54 billion, with diluted EPS from continuing operations of US$3.11, all higher than a year earlier. Alongside these results, Centene raised its 2026 guidance, lifting expected total revenue to between US$187.50 billion and US$191.50 billion and increasing its GAAP diluted EPS outlook to above US$2.37, signaling management’s confidence in ongoing margin and cost initiatives. We’ll now...

In late April 2026, JANA Partners sent a letter to Markel Group’s board urging a divestiture of Markel Ventures and a US$2.00 billion share repurchase tender, while questioning incentive payouts and arguing that the Ventures segment has diluted the value of the core insurance business. This activist push brings Markel’s long-standing “forever home” pledge to acquired businesses into direct tension with shareholder priorities around capital allocation and corporate structure. We’ll now...

In late April 2026, Varonis Systems reported first-quarter revenue of US$173.13 million, a similar loss per share as a year earlier, completed a US$149.99 million buyback program, and issued guidance calling for double-digit revenue growth for the second quarter and full year 2026. At the same time, Varonis highlighted surging demand for its AI and data security platform, including new ENS High certification in Spain and stronger SaaS adoption, reinforcing its role in securing the data that...

White Mountains Insurance Group reported first-quarter 2026 results showing revenue of US$517.8 million and a net loss of US$27.2 million, reversing a profit a year earlier as investment losses pushed basic and diluted loss per share from continuing operations to US$12.59. Beneath the headline loss, the company’s Ark/WM Outrigger insurance operations produced strong underwriting results, while a large unrealized loss on its MediaAlpha stake and a 1% decline in book value per share...

Viking Holdings (NYSE:VIK) opened bookings for its expanded 2028–2029 expedition voyages. The company added new departure dates and extra sailings in the Arctic, Antarctica, and the Great Lakes. The move widens Viking's expedition footprint across remote and cold-weather destinations. Viking Holdings, listed as NYSE:VIK, focuses on premium cruises, including ocean, river, and expedition offerings. The decision to expand expedition sailings in 2028 and 2029 in the Arctic, Antarctica, and the...

Hims & Hers Health (HIMS) heads into its May 11 earnings report under closer watch as investors weigh margin concerns, rising competitive and legal pressures, and recent board changes that reshape the company’s governance profile. See our latest analysis for Hims & Hers Health. Short term sentiment has cooled, with a 1 day share price return showing a decline of 4.58% and a 7 day share price return showing a decline of 5.59%. However, the 30 day share price return of 31.54% and multi year...